Absorption, distribution, metabolism, and excretion of [14C]sesamin in rats

Molecular Nutrition and Food Research

Volumn 61, Issue 8, 2017, Pages

  Tomimori, Namino ^a   Rogi, Tomohiro ^a   Shibata, Hiroshi ^a  

^a Suntory Wellness Limited Research Center   (Japan)

Author keywords

Distribution; Excretion; Metabolites profile; Pharmacokinetics; Sesamin

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; CARBON; LIGNAN; SESAMIN;

ANIMAL; BILE; FECES; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ANIMALS; BILE; CARBON RADIOISOTOPES; DIOXOLES; FECES; LIGNANS; MALE; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 85012876527     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600844     Document Type: Article

References (34)

1. Nakai, M., Harada, M., Nakahara, K., Akimoto, K. et al., Novel antioxidative metabolites in rat liver with ingested sesamin. J. Agric. Food. Chem. 2003, 51, 1666–1670.
2. Ikeda, T., Nishijima, Y., Shibata, H., Kiso, Y. et al., Protective effect of sesamin administration on exercise-induced lipid peroxidation. Int. J. Sports Med. 2003, 24, 530–534.
3. Kiso, Y., Antioxidative roles of sesamin, a functional lignan in sesame seed, and it's effect on lipid- and alcohol-metabolism in the liver: a DNA microarray study. Biofactors 2004, 21, 191–196.
4. Tada, M., Ono, Y., Nakai, M., Harada, M. et al., Evaluation of antioxidative effects of sesamin on the in vivo hepatic reducing abilities by a radiofrequency ESR method. Anal. Sci. 2013, 29, 89–94.
5. Takada, S., Kinugawa, S., Matsushima, S., Takemoto, D. et al., Sesamin prevents decline in exercise capacity and impairment of skeletal muscle mitochondrial function in mice high-fat diet-induced diabetes. Exp. Physiol. 2015, 100, 1319–1330.
6. Hirose, N., Inoue, T., Nishihara, K., Sugano, M. et al., Inhibition of cholesterol absorption and synthesis in rats by sesamin. J. Lipid Res. 1991, 32, 629–638.
7. Peñalvo, J. L., Hopia, A., Adlercreutz, H., Effect of sesamin on serum cholesterol and triglycerides levels in LDL receptor-deficient mice. Eur. J. Nutr. 2006, 45, 439–444.
8. Nakabayashi, A., Kitagawa, Y., Suwa, Y., Akimoto, K. et al., alpha-Tocopherol enhances the hypocholesterolemic action of sesamin in rats. Int. J. Vitam. Nutr. Res. 1995, 65, 162–168.
9. Hirata, F., Fujita, K., Ishikura, Y., Hosoda, K. et al., Hypocholesterolemic effect of sesame lignan in humans. Atherosclerosis 1996, 122, 135–136.
10. Kiso, Y., Tsuruoka, N., Kidokoro, A., Matsumoto, I. et al., Sesamin ingestion regulates the transcription levels of hepatic metabolizing enzymes for alcohol and lipids in rats. Alcohol. Clin. Exp. Res. 2005, 29, 116S–120S.
11. Kita, S., Matsumura, Y., Morimoto, S., Akimoto, K. et al., Antihypertensive effect of sesamin. II. Protection against two-kidney, one-clip renal hypertension and cardiovascular hypertrophy. Biol. Pharm. Bull. 1995, 18, 1283–1285.
12. Matsumura, Y., Kita, S., Morimoto, S., Akimoto, K. et al., Antihypertensive effect of sesamin. I. Protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy. Biol. Pharm. Bull. 1995, 18, 1016–1019.
13. Lee, C. C., Chen, P. R., Lin, S., Tsai, S. C. et al., Sesamin induces nitric oxide and decreases endothelin-1 production in HUVECs: possible implications for its antihypertensive effect. J. Hypertens. 2004, 22, 2329–2338.
14. Nakano, D., Kwak, C. J., Fujii, K., Ikemura, K. et al., Sesamin metabolites induce an endothelial nitric oxide-dependent vasorelaxation through their antioxidative property-independent mechanisms: possible involvement of the metabolites in the antihypertensive effect of sesamin. J. Pharmacol. Exp. Ther. 2006, 318, 328–335.
15. Miyawaki, T., Aono, H., Toyoda-Ono, Y., Maeda, H. et al., Antihypertensive effects of sesamin in humans. J. Nutr. Sci. Vitaminol. 2009, 55, 87–91.
16. Akimoto, K., Kitagawa, Y., Akamatsu, T., Hirose, N. et al., Protective effects of sesamin against liver damage caused by alcohol or carbon tetrachloride in rodents. Ann. Nutr. Metab. 1993, 37, 218–224.
17. Li, L. C., Piao, H. M., Zheng, M. Y., Lin, A. H. et al., Sesamin attenuates mast cell-mediated allergic responses by suppressing the activation of p38 and nuclear factor-κB. Mol. Med. Rep. 2016, 13, 536–542.
18. Yamashita, K., Kagaya, M., Higuti, N., Kiso, Y., Sesamin and alpha-tocopherol synergistically suppress lipid-peroxide in rats fed a high docosahexaenoic acid diet. Biofactors 2000, 11, 11–13.
19. Umeda-Sawada, R., Ogawa, M., Ogarashi, O., The metabolism and distribution of sesame lignans (sesamin and episesamin) in rats. Lipids 1999, 34, 633–637.
20. Yasuda, K., Sakaki, T., How is sesamin metabolised in the human liver to show its biological effects? Expert Opin. Drug Metab. Toxicol. 2012, 8, 93–102.
21. Yasuda, K., Ikushiro, S., Kamakura, M., Munetsuna, E. et al., Sequential metabolism of sesamin by cytochrome P450 and UDP-glucuronosyltransferase in human liver. Drug Metab. Dispos. 2011, 39, 1538–1545.
22. Liu, Z., Saarinen, N. M., Thompson, L. U., Sesamin is one of the major precursors of mammalian lignans in sesame seed (Sesamum indicum) as observed in vitro and in rats. J. Nutr. 2006, 136, 906–912.
23. Kim, J. C., Kim, K. H., Jung, J. C., Park, O. S., An efficient asymmetric synthesis of furofuran lignans: (+)-sesamin and (−)-episesamin. Tetrahedron Asymmetry 2006, 17, 3–6.
24. Urata, H., Nishioka, Y., Tobashi, T., Matsumura, Y. et al., First chemical synthesis of antioxidative metabolites of sesamin. Chem. Pharm. Bull. 2008, 56, 1611–1612.
25. Bligh, E. G., Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37, 911–917.
26. Porter, C. J., Charman, W. N., Intestinal lymphatic drug transport: an update. Adv. Drug Deliv. Rev. 2001, 50, 61–80.
27. Hirose, N., Inoue, T., Nishihara, K., Sugano, M. et al., Inhibition of cholesterol absorption and synthesis in rats by sesamin. J. Lipid Res. 1991, 32, 629–638.
28. Yasuda, K., Ikushiro, S., Kamakura, M., Ohta, M. et al., Metabolism of sesamin by cytochrome P450 in human liver microsomes. Drug. Metab. Dispos. 2010, 38, 2117–2123.
29. Mullen, W., Edwards, C. A., Crozier, A., Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl-, and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br. J. Nutr. 2006, 96, 107–116.
30. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E. Jr et al., High absorption but very low bioavailability of oral resveratrol in humans. Drug. Metab. Dispos. 2004, 32, 1377–1382.
31. Walle, U. K., Galijatovic, A., Walle, T., Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell Caco-2. Biochem. Pharmacol. 1999, 58, 431–438.
32. Nakano, D., Kurumazuka, D., Nagai, Y., Nishiyama, A. et al., Dietary sesamin suppresses aortic NADPH oxidase in DOCA salt hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2008, 35, 324–326.
33. Ishizawa, K., Yoshizumi, M., Kawai, Y., Terao, J. et al., Pharmacology in health food: metabolism of quercetin in vivo and its protective effects against arteriosclerosis. J. Pharmacol. Sci. 2011, 115, 466–470.
34. Calamini, B., Ratia, K., Malkowski, M. G., Cuendet, M. et al., Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem. J. 2010, 429, 273–282.